Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease
Chronic respiratory diseases are the third leading cause of death, behind cardiovascular diseases and cancer, affecting approximately 550 million of people all over the world. Most of the chronic respiratory diseases are attributable to asthma and chronic obstructive pulmonary disease (COPD) with th...
Enregistré dans:
Auteurs principaux: | Fabrizio Facchinetti, Maurizio Civelli, Dave Singh, Alberto Papi, Aida Emirova, Mirco Govoni |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/622a70fbc2e348a4a103a94d0a8020b0 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Phosphodiesterase-4 Inhibition in Psoriasis
par: Milakovic M, et autres
Publié: (2021) -
Pharmaco-Metabolomics of Inhaled Corticosteroid Response in Individuals with Asthma
par: Priyadarshini Kachroo, et autres
Publié: (2021) -
The Involvement of PDE4 in the Protective Effects of Melatonin on Cigarette-Smoke-Induced Chronic Obstructive Pulmonary Disease
par: Je-Oh Lim, et autres
Publié: (2021) -
Lung Health in the Solomon Islands: A Mixed Methods Study
par: Di Michiel J, et autres
Publié: (2021) -
The Role of PDE11A4 in Social Isolation-Induced Changes in Intracellular Signaling and Neuroinflammation
par: Katy Pilarzyk, et autres
Publié: (2021)